Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5784]

UBE2V1 promotes hepatocellular carcinoma progression by forming a positive feedback loop with HIF-1α

UBE2V1 promotes hepatocellular carcinoma progression by forming a positive feedback loop with HIF-1α

Severe COVID-19, flu facilitate lung cancer months or years later, new research shows

Severe COVID-19, flu facilitate lung cancer months or years later, new research shows

Turning cancer’s protein machinery against itself to boost immunity

Turning cancer’s protein machinery against itself to boost immunity

Why ‘being squeezed’ helps breast cancer cells to thrive

Why ‘being squeezed’ helps breast cancer cells to thrive

Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?

Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?

Cryotherapy could be a game changer for patients with early-stage kidney cancer

Cryotherapy could be a game changer for patients with early-stage kidney cancer

Overcoming ovarian cancer’s resistance to immunotherapy

Overcoming ovarian cancer’s resistance to immunotherapy

Innovative combination therapy shows promising efficacy in aggressive leukaemia

Innovative combination therapy shows promising efficacy in aggressive leukaemia

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer-free longer

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer...

More from ecancer